Featured Resources
25:06
Assigning function to the structure of HIV and SARS-CoV-2 glycan shields

Weston Struwe of the University of Oxford describes the analysis of HIV and SARS-CoV-2 viral spikes and illustrate how glycomics/ glycoproteomics datasets can inform on their structural assembly and biological functions.

38:20
EAD: Making characterization of complex biotherapeutics routine

A new fragmentation technique with Sciex's ZenoTOF 7600 with a deep dive into the characterization of PTMs, S-S bond mapping and more with Byos

47:05
Analytical Characterization of Oligonucleotides by LC-HRMS and BYOS

Joint presentation with Phenomenex, we show novel automatic identification of process-related impurities using high-resolution MS (HRMS), new LC columns for oligo analysis, and novel deconvolution / mass-matching software.

33:32
Characterizing the glycan shield of the Hepatitis C E1E2 glycoprotein complex using mass spectrometry

Maddy Newby takes us through the steps for unravelling the structural details of the E1E2 glycoprotein complex whilst also uncovering a novel glycan site within a non-canonical N-linked glycan site.

54:23
Neutrophil azurophilic granule glycoproteins – atypical glycans

Glycoproteomics analysis of complex samples. What is the Impact of sample preparation, mass spectrometry and data analysis on your observed glycoproteome?

42:43
From Here to Byosphere

A Global Biotherapeutic CDMO’s approach to Mass Spectrometry data processing

posters
published articles
Briefs
Insights
Download Information & system requirements
×